Navigation Links
PharmAthene Announces New Date for First Quarter 2009 Conference Call and Webcast
Date:5/8/2009

ANNAPOLIS, Md., May 8 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP) a biodefense company developing medical countermeasures against biological and chemical threats, announced a date change for its first quarter 2009 financial results. The Company's first quarter 2009 financial results will now be released on Friday, May 15, 2009.

PharmAthene management will be hosting a conference call to discuss its first quarter 2009 financial results. The call is scheduled to begin at 10:00 a.m. Eastern Time on Friday, May 15, 2009, and is expected to last approximately 45 minutes.

The dial-in number within the United States is 866-783-2137. The dial-in number for international callers is 857-350-1596. The participant passcode is 47746139.

A replay of the conference call will be available beginning at approximately 1:00 p.m. Eastern Time on May 15, 2009 until approximately 11:59 p.m. Eastern Time June 30, 2009. The dial-in number from within the United States is 888-286-8010. For international callers, the dial-in number is 617-801-6888. The participant passcode is 34158052.

The conference call will also be webcast and can be accessed from the company's website at www.PharmAthene.com. A link to the webcast may be found under the Investor Relations section of the website. The webcast will be available for 30 days, or until approximately June 15, 2009.


'/>"/>
SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. PharmAthene to Host First Quarter 2009 Conference Call and Webcast on Thursday, May 14, 2009
2. PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research
3. PharmAthene Announces $5.5 Million Public Equity Offering
4. PharmAthene To Host Year-End 2008 Earnings Conference Call and Webcast on Monday, March 30, 2009
5. PharmAthene Presents Data for SparVax(TM) and Valortim(R), a Novel Vaccine and Anti-Toxin for the Prevention and Treatment of Anthrax Infection at the 7th Annual ASM Biodefense Meeting
6. PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel
7. Pharmathene Reports Third Quarter 2008 Financial and Operational Results
8. PharmAthene to Host Third Quarter 2008 Conference Call and Webcast on Thursday, November 13, 2008
9. PharmAthene to Present on Wednesday, November 12th at the 10th Annual Rodman & Renshaw Healthcare Conference
10. Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R)
11. PharmAthene and Panacea Biotec Ltd. Establish Strategic Alliance in Biodefense and Emerging Infectious Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2019)... (PRWEB) , ... December 03, 2019 , ... A new ... have shown can reduce and even reverse fibrosis (scar tissue) buildup – also improves ... Stanford University School of Medicine, was conducted on mice. , The tumor-destroying capabilities ...
(Date:12/2/2019)... ... December 02, 2019 , ... Registration is now ... Meeting, which will be held at the Hynes Convention Center May 12-15, 2020, in ... therapy and brings together scientists, physicians, patient advocates, and other stakeholders with the goal ...
(Date:11/22/2019)... ... November 21, 2019 , ... Lajollacooks4u is preparing for another busy ... company already scheduled several of its popular cooking classes and team-building events, but the ... The company’s Holiday Parties have been a favorite for companies of all sizes since ...
(Date:11/12/2019)... ... 2019 , ... REPROCELL Inc. a stem cell and drug ... to provided preclinical screening and drug sensitivity for its portfolio of oncology drugs. ... unique and genetically edited cell lines from various tumors. The data generated from ...
Breaking Biology Technology:
(Date:11/19/2019)... N.J. and HERCULES, Calif. (PRWEB) , ... November ... ... of solutions for epigenetics research and sample preparation, and Bio-Rad Laboratories, Inc. (NYSE: ... products, today announced a partnership in which Diagenode will offer Single-Cell ATAC-Seq (scATAC-Seq) ...
(Date:11/14/2019)... ... November 13, 2019 , ... Personalized Stem Cells, Inc (“PSC”), ... FDA approved clinical trial for stem cell treatment of knee osteoarthritis . The ... as a subsidiary of VetStem Biopharma. , In July of 2019, PSC received ...
(Date:11/12/2019)... ... November 12, 2019 , ... The Arnold and Mabel Beckman ... research institutions for its Instrumentation Grant for Advanced Light-Sheet Microscopy and Data ... site for the acquisition of instrumentation, development and maintenance; support for data science ...
Breaking Biology News(10 mins):